We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

44 hedge funds and large institutions have $5.52M invested in TherapeuticsMD in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $3.54M → $5.52M (+$1.97M)

0.7% more ownership

Funds ownership: 28.55% → 29.25% (+0.7%)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

4% less funds holding

Funds holding: 46 → 44 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
7
Closed
6
Calls
$113K
Puts
–
Net Calls
+$113K
Net Calls Change
+$109K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$88.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$50.8K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$29.2K
4
Osaic Holdings
Osaic Holdings
Arizona
+$12.1K
5
TC
Tejara Capital
United Kingdom
+$9.61K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$24.6K
2
JGC
J. Goldman & Co
New York
-$14.6K
3
TSS
Two Sigma Securities
New York
-$12.9K
4
Citadel Advisors
Citadel Advisors
Florida
-$8.72K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$4.31K
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
26
Huntington National Bank
Ohio
$196 – – –
Bank of America
27
Bank of America
North Carolina
$176 +$3 +2 +2%
AWM
28
Activest Wealth Management
Florida
$65 – – –
Wells Fargo
29
Wells Fargo
California
$60 – – –
SPIA
30
Steward Partners Investment Advisory
New York
$57 – – –
FFA
31
Farther Finance Advisors
California
$49 – – –
IA
32
IFP Advisors
Florida
$34 – – –
PWA
33
Provenance Wealth Advisors
Florida
$33 – – –
CIBC Private Wealth Group
34
CIBC Private Wealth Group
Georgia
$33 +$29 +20 New
TC
35
Truvestments Capital
Florida
$16 – – –
HI
36
Harbour Investments
Wisconsin
$13 – – –
AssetMark Inc
37
AssetMark Inc
California
$7 – – –
SWIM
38
Smallwood Wealth Investment Management
New Jersey
$3 – – –
Citigroup
39
Citigroup
New York
$2 – – –
EWA
40
EverSource Wealth Advisors
Alabama
$2 – – –
SA
41
Strategic Advocates
Utah
$2 – – –
JGC
42
J. Goldman & Co
New York
– -$14.6K -13,562 Closed
TSS
43
Two Sigma Securities
New York
– -$12.9K -11,967 Closed
Barclays
44
Barclays
United Kingdom
– -$47 -44 Closed
WWA
45
Wealth Watch Advisors
Colorado
– -$24 -22 Closed
ASN
46
Advisory Services Network
Georgia
– -$15 -14 Closed
NA
47
NewEdge Advisors
Louisiana
– -$1 -1 Closed
1
2

TXMD Hedge Fund Activity: Q4 2025 in Review

44 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2025, worth a combined $5.52M — up 56% from $3.54M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TXMD and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $88.2K. The largest seller was Bridgeway Capital Management, cutting an estimated $24.6K.

  • 44 institutional investors held TherapeuticsMD (TXMD) as of Q4 2025, down from 46 in Q3 2025.
  • Funds reported $5.52M of TherapeuticsMD stock for Q4 2025, up 56% quarter-over-quarter.
  • 4 funds opened new TherapeuticsMD positions in Q4 2025 and 6 closed out, a net change of -2 holders.
  • The largest TherapeuticsMD buyer in Q4 2025 was Renaissance Technologies, an estimated $88.2K added.
  • The largest TherapeuticsMD seller in Q4 2025 was Bridgeway Capital Management, an estimated $24.6K sold.

Based on aggregated 13F filings for Q4 2025.